1)水島裕,稲葉午朗,三村康夫,他.1987年度診断基準と治療の手びき.最新医学 43 : 382-391, 1988
2)馬場正三.腸型Behçet病の臨床.胃と腸 14 : 885-892, 1979
3)武藤徹一郎.いわゆる“Simple Ulcer”とは.胃と腸 14 : 739-748, 1979
4)八尾恒良.腸管Behçet病とSimple ulcer.胃と腸 27 : 273-275, 1992
5)渡辺英伸,遠城寺宗知,八尾恒良.回盲弁近傍の単純性潰瘍の病理.胃と腸 14 : 749-767, 1979
6)渡辺英伸.非腫瘍性腸疾患の病理.病理と臨 2 : 1219-1230, 1984
7)Matsukawa M, Yamasaki T, Kouda T, et al. Endoscopic therapy with absolute ethanol for postoperative recurrent ulcers in intestinal Behçet's disease, and simple ulcers. J Gastroenterol 36 : 255-258, 2001
8)松川正明,関川高志,久保定徳,他.腸管ベーチェット病・単純性潰瘍.INTESTINE 14 : 52-56, 2010
9)Hamzaoui K, Hamza M, Ayed K. Production of TNF-alpha and IL-1 in active Behçet's disease. J Rheumatol 17 : 1428-1429, 1990
10)Akoglu TF, Direskeneli H, Yazici H, et al. TNF, soluble IL-2R and soluble CD-8 in Behçet's disease. J Rheumatol 17 : 1107-1108, 1990
11)Hassard PV, Binder SW, Nelson V, et al. Anti-tumor necrosis factor monoclonal antibody therapy for gastrointestinal Behçet's disease : a case report. Gastroenterology 120 : 995-999, 2001
12)Kram MT, May LD, Goodman S, et al. Behçet's ileocolitis : successful treatment with tumor necrosis factor-alpha antibody(infliximab)therapy : report of a case. Dis Colon Rectum 46 : 118-121, 2003
13)Naganuma M, Sakuraba A, Hisamatsu T, et al. Efficacy of infliximab for induction and maintenance of remission in intestinal Behçet's disease. Inflamm Bowel Dis 14 : 1259-1264, 2008
14)Shek LP, Lim DL. Thalidomide in Behçet's disease. Biomed Pharmacother 56 : 31-35, 2002
15)Postema PT, den Haan P, van Hagen PM, et al. Treatment of colitis in Behçet's disease with thalidomide. Eur J Gastroenterol Hepatol 8 : 929-931, 1996
16)Direskeneli H, Ergun T, Yavuz S, et al. Thalidomide has both anti-inflammatory and regulatory effects in Behçet's disease. Clin Rheumatol 27 : 373-375, 2008